Effect of codeine on CYP450 isoform activity of rats

References

• Andresen H, Augustin C, Streichert T. 2013. Toxicogenetics-cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam. Int J Legal Med. 127:395–404.
   PubMed Web of Science ®Google Scholar
• Asturias-Arribas L, Alonso-Lomillo MA, Dominguez-Renedo O, Arcos-Martinez MJ. 2014. Cytochrome P450 2D6 based electrochemical sensor for the determination of codeine. Talanta. 129:315–319.
   PubMed Web of Science ®Google Scholar
• Chen A, Zhou X, Tang S, Liu M, Wang X. 2016. Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach. Sci Rep. 6:28482.
   PubMed Web of Science ®Google Scholar
• Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, Kharasch ED, Skaar TC. Clinical Pharmacogenetics Implementation Consortium. 2012. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther. 91:321–326.
   PubMed Web of Science ®Google Scholar
• Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, Haidar CE, Shen DD, Callaghan JT, Sadhasivam S, Clinical Pharmacogenetics Implementation Consortium, et al. 2014. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther. 95:376–382.
   PubMed Web of Science ®Google Scholar
• Derungs A, Donzelli M, Berger B, Noppen C, Krahenbuhl S, Haschke M. 2016. Effects of cytochrome P450 inhibition and induction on the phenotyping metrics of the basel cocktail: a randomized crossover study. Clin Pharmacokinet. 55:79–91.
   PubMed Web of Science ®Google Scholar
• Dinger J, Meyer MR, Maurer HH. 2014. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 230:28–35.
   PubMed Web of Science ®Google Scholar
• Fernandes LC, Kilicarslan T, Kaplan HL, Tyndale RF, Sellers EM, Romach MK. 2002. Treatment of codeine dependence with inhibitors of cytochrome P450 2D6. J Clin Psychopharmacol. 22:326–329.
   PubMed Web of Science ®Google Scholar
• Frost J, Helland A, Nordrum IS, Slordal L. 2012. Investigation of morphine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths. Forensic Sci Int. 220:6–11.
   PubMed Web of Science ®Google Scholar
• Geng P, Wang S, Wang C, Chen J, Zhang L, Yang S, Wen C, Zhou Y, Zhang M. 2015. Evaluation of the impact of Flos Daturae on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. Int J Clin Exp Med. 8:22310–22318.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 2008. Cytochrome p450 and chemical toxicology. Chem Res Toxicol. 21:70–83.
   PubMed Web of Science ®Google Scholar
• Havig SM, Wiik E, Karinen R, Brochmann GW, Vevelstad M. 2016. Codeine-spiked beer in a date rape case? Int J Legal Med. 130:1513–1518.
   PubMed Web of Science ®Google Scholar
• Hudak ML. 2016. Codeine pharmacogenetics as a proof of concept for pediatric precision medicine. Pediatrics. 138:e20161359. doi: 10.1542/peds.2016-1359.
   PubMed Web of Science ®Google Scholar
• Kathiramalainathan K, Kaplan HL, Romach MK, Busto UE, Li NY, Sawe J, Tyndale RF, Sellers EM. 2000. Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. J Clin Psychopharmacol. 20:435–444.
   PubMed Web of Science ®Google Scholar
• Kimergard A, Deluca P, Hindersson P, Breindahl T. 2016. How resistant to tampering are codeine containing analgesics on the market? Assessing the potential for opioid extraction. Pain Ther. 5:187–201.
   PubMed Web of Science ®Google Scholar
• Li G, Huang K, Nikolic D, van Breemen RB. 2015. High-throughput cytochrome P450 cocktail inhibition assay for assessing drug-drug and drug-botanical interactions. Drug Metab Dispos. 43:1670–1678.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang S, Zhang M, Zhang Q, Zhou Y, Lin C, Lin G, Wang X. 2015. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats. Biomed Chromatogr. 29:1203–1212.
   PubMed Web of Science ®Google Scholar
• Madadi P, Ciszkowski C, Gaedigk A, Leeder JS, Teitelbaum R, Chitayat D, Koren G. 2011. Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine. Curr Drug Saf. 6:36–39.
   PubMedGoogle Scholar
• Prommer E. 2011. Role of codeine in palliative care. J Opioid Manag. 7:401–406.
   PubMedGoogle Scholar
• Romach MK, Otton SV, Somer G, Tyndale RF, Sellers EM. 2000. Cytochrome P450 2D6 and treatment of codeine dependence. J Clin Psychopharmacol. 20:43–45.
   PubMed Web of Science ®Google Scholar
• Saad M, Cavanaugh K, Verbueken E, Pype C, Casteleyn C, Van Ginneken C, Van Cruchten S. 2016. Xenobiotic metabolism in the zebrafish: a review of the spatiotemporal distribution, modulation and activity of Cytochrome P450 families 1 to 3. J Toxicol Sci. 41:1–11.
   PubMed Web of Science ®Google Scholar
• Wilcox RA, Owen H. 2000. Variable cytochrome P450 2D6 expression and metabolism of codeine and other opioid prodrugs: implications for the Australian anaesthetist. Anaesth Intensive Care. 28:611–619.
   PubMed Web of Science ®Google Scholar
• Wiseman H, Lewis DF. 1996. The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions. Carcinogenesis. 17:1357–1360.
   PubMed Web of Science ®Google Scholar
• Zhu X, Lee DY, Shin WG. 2007. Gender difference in the pharmacokinetic interaction between oral warfarin and oxolamine in rats: inhibition of CYP2B1 by oxolamine in male rats. Biopharm Drug Dispos. 28:125–133.
   PubMed Web of Science ®Google Scholar